Back to top

Janus Global Life Sciences D Shs: (MF: JNGLX)

(MF) As of Apr 22, 2014 06:05 PM ET

 Add to portfolio

$44.96 USD

+1.03 (2.35%)

Zacks MF Rank : 2 - Buy [?]   2      

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Mar 31, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Mar 31, 2014) 7.19
Objective* Equity - Sector Health
Peer* HL LG

*Key

Zacks Premium Research for JNGLX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Rank Change Trend Buy 2
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 33.52
Net Assets (Mil $) 3/31/2014 846.77
%Turnover 3/31/2014 47.00

Allocation

% of Portfolio
Large Growth 17.76
Large Value 0.00
Small Growth 4.55
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 27.99
High Yield Bond 21.84

Sector / Country Weightings

As of 3/31/2014 % of Portfolio
Health 50.66
Services 16.75
Other 13.21
Industrial Cyclical 8.19
Finance 5.11
Retail Trade 2.60
Technology 2.38
Non-Durable 1.10

Portfolio Holdings

Top Equity Holdings
(As of 12/31/2013)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 4.71 74.82
EXPRESS SCRIPTS HOLDING C 3.13 49.78
AETNA INC 3.09 49.16
CELGENE CORP 2.90 46.06
ROCHE HOLDING AG GENUSSS 2.53 40.25
BIOGEN IDEC INC 2.48 39.40
VALEANT PHARMACEUTICALS 2.28 36.27
NPS PHARMACEUTICALS INC 2.18 34.59
JOHNSON & JOHNSON 2.17 34.51

Stock Holding % of Net Assets

As Of 12/31/2013
Total Issues 84
Avg. P/E 28.85
Avg. P/Book 5.42
Avg. EPS Growth 16.45
Avg. Market Value (Mil $) 38,103

Risk

3 Year 5 Year 10 Year
Beta 0.85 0.71 0.77
Alpha 14.26 10.38 5.68
R Squared 0.55 0.51 0.58
Std. Dev. 14.43 13.93 14.99
Sharpe 2.01 1.95 2.00